Balance wanting low prices for generics but also wanting enough competitors in the market.
The Indian pharmaceutical industry has become almost synonymous with the US regulatory authorities. The Indian firms that have slowly expanded their market share in the generics segment have been facing…
The global dry eye syndrome treatment market accounted for USD 3.42 billion in 2016 growing at a CAGR of 6.9% during the forecast period of 2017 to 2024.
Dry eye syndrome treatment research report 2019 is a comprehensive, professional report delivering market research data that is relevant for new market entrants or established players. The research study covers…
Investor eyes on launch of the Indian pharma industry new drugs in the US
Nine Masts Capital Ltd increased its stake in United Parcel Service Inc (Put) (UPS) by 9900% based on its latest 2018Q4 regulatory filing with the SEC. Nine Masts Capital Ltd…
Journalist Katherine Eben’s book ‘Bottle of Lies’ puts Indian drug companies in the dock
‘Bottle of Lies’ opens a can of worms for Indian drug companies. The new book by Katherine Eban, called an “invaluable exposé” by The New York Times, alleges severe cases…
Quality @reasonable Price is the sine qua non of Taiwan Healthcare Products
New Delhi: Quality at par with USA and European countries but at lower price was what Taiwan flaunted as strength of its healthcare products in Taiwan Expo at Pragati Maidan.…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
In April MF Invested In IT, Pharma And Telecom
In the absence of earnings growth triggers, which has shrunk the universe of investible ideas, leading fund houses have resorted to selling more of a part of their portfolios than…
Sun Pharma Dropped In Market After Us Lawsuit
Share prices of some leading domestic pharmaceutical companies, led by Sun Pharmaceutical Industries, fell 4-9 per cent on Monday, after being named in a price-fixing lawsuit in the US. The…
Large pharma companies increase prices ofgeneric drugs by up to one thousand percent
Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on…
The Supreme Court arrived against the nomination rejection PS Chatwal will keep its favour
Torak Pharmaceutical company managing director PS Chatwal has now appealed to the Supreme Court against the rejection of the nomination. Chatwal said that the election commission has also been in…
